28Mar 2018

OPTIMIZATION AND CHARACTERIZATION OF 5-FLUOROURACIL TRANSETHOSOMES FOR SKIN CANCER THERAPY USING RESPONSE SURFACE METHODOLOGY.

  • Dept of Pharmaceutics, Prin. K. M. Kundnani College of Pharmacy, Cuffe Parade, Mumbai 400005, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The purpose of the present study was to develop, optimize and characterize 5-Fluorouracil transethosomes for skin cancer targeting. 5- Fluorouracil transethosomes were prepared by cold method using phospholipon 90G as the lipid and sodium cholate as edge activator. The size reduction was done by probe sonication. Central composite design was used for optimization procedure with different concentration of phospholipon 90G and sodium cholate as independent variables. The response variables selected were particle size and entrapment efficiency. Particle size and entrapment efficiency depends on the quantity of the above independent variables. Mathematical equation and response surface plots were used to relate the dependent and independent variables. The optimized model predicted a particle size of 57nm and entrapment efficiency of 92.06%. Transethosomes proved to be superior in terms of, amount of drug permeated in the skin as compared to conventional 1% flonida cream. The results suggests that transethosomes are efficient carriers for transdermal delivery of 5- Fluorouracil.

  1. Abraham W, Downing D. (1991) Deuterium NMR investigation of polymorphism in stratum corneum lipids. Biochimica et Biophysica Acta (BBA)-Biomembranes.;1068(2):189-194.
  2. Aggarwal N, Goindi S. (2012) Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of microsporum canis dermatophytosis. International journal of pharmaceutics; 437(1):277-287.
  3. Ainbinder D, Touitou E. (2005) Testosterone ethosomes for enhanced transdermal delivery. Drug delivery; 12(5):297-303.
  4. Andrea Ascenso, Sara Raposo et al. (2015) Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomedicine; 10: 5837?5851.
  5. Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, et al. (2009) Formulation and in vitro assessement of minoxidil niosomes for enhanced skin delivery. Int J Pharm; 377:1-8.
  6. Bhana R, Verma A, Jain S. (2013) Development and characterization of ethosomes bearing losartan potassium for transdermal drug delivery. Int J Pharm Pharm Sci.;5(1):35?40.
  7. Cevc, G. (2003) Lipid vesicles and other colloids as drug carriers on the skin, 56, 675?711 DOI: 10.1016/j.addr.10.028.
  8. Chen JG, Jiang Y, Yang Z. (2012) Preparation of triptolide ethosomes. Afr J Pharm Pharmacol.;6(13):998?1004.
  9. Dianzani, C.; Zara, G. P.; Maina, G.; Pettazzoni, P.; Pizzimenti, S.; Rossi, F.; Gigliotti, C. L.; Ciamporcero, E. S.; Daga, M.; Barrera, G. (2014) Drug Delivery Nanoparticles in Skin Cancers.
  10. Esposito E, Menegatti E, Cortesi R. (2004) Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosmet Sci; 55(3):253?264.
  11. Filipe V, Hawe A, Jiskoot W. (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm Res; 27:796?810.
  12. Goindi S, Dhatt B, Kaur A. (2014) Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies. J Microencapsul: 31(7):716?724.
  13. Irfan, M.; Verma, S.; Ram, A. (2012) PREPARATION AND CHARACTERIZATION OF IBUPROFEN LOADED TRANSFEROSOME AS A NOVEL CARRIER FOR TRANSDERMAL DRUG DELIVERY SYSTEM, 5 (3), 3?6.
  14. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. (2005) Vesicular approach for drug delivery into or across the skin: current status and future prospects. Curr Drug Delivery; 2:222-33.
  15. Kaiser, N.; Kimpfler, A.; Massing, U.; Burger, A. M.; Fiebig, H. H.; Brandl, M.; Schubert, R. (2003) 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment : entrapment and release properties, 256, 123?131.
  16. Karim, N. A. (2016) Ethosomal nanocarriers : the impact of constituents and formulation techniques on ethosomal properties , in vivo studies , and clinical trials, 2279?2304.
  17. Kirjavainen M, Monkkonen J, Saukkosaari M, Valjakka-Koskela R, Keisvaara J, Urtti A. (1999) Phospholipids affects stratum corneum lipid bilayer fluidity and drug portioning into the bilayers. J Control Release; 58, 207-14.
  18. Lalit kumar, Shivani Verma, Kuljit Singh, Deo Prasad, Amit Jain. (2016) Ethanol Based Vesicular Carriers in Transdermal Drug Delivery: Nanoethosomes and Transethosomes in Focus. Nano World Journal 030, 41-51.
  19. Nandan, D.; Shivalik, P. (2016) Ethanol Based Vesicular Carriers in Transdermal Drug Delivery : Nanoethosomes and Transethosomes in Focus Ethanol Based Vesicular Carriers in Transdermal Drug, No. October DOI: 10.17756/nwj. 030.
  20. Nayak AK, Mohanty B, Sen K. (2010) Comparative evaluation of invitro diclofenac sodium permeability across excised mouse skin from different common pharmaceutical vehicles. Int J Pharm Tech Res; 2:920?30.
  21. Nidhi Pandey, (2011) PRONIOSOMES AND ETHOSOMES: NEW PROSPECT IN TRANSDERMAL AND DERMAL DRUG DELIVERY SYSTEM, KIET School of Pharmacy, Ghaziabad, Uttar Pradesh, India, 2(8), 1988?1996.
  22. Peters GJ, Jansen G: Resistance to antimetabolites, in Schilsky RL, Milano GA, Ratain MJ (eds): (1996) Principles of Antineoplastic Drug Development and Pharmacology, New York, Marcel Dekker, Inc., pp 543-585.
  23. Rigon, R. B.; Oyafuso, M. H.; Fujimura, A. T.; Gon?alez, M. L.; Haddad, A.; Palmira, M.; Gremi?o, D.; Chorilli, M. (2015) Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy : A Review. Biomed research international.
  24. Sathya Prasad S, et al.(2013) Ethosomes as Drug Carrier: A Novel Approach. Int journal of innovative drug discovery, 3(2), 55-66.
  25. Shaji, J.; Garude, S. http://www.iajpr.com. 2014, 4 (08).
  26. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A. (2001) Intracellur delivery mediated by an ethosomal carrier. Biomater, 22:3053-9.
  27. Vikas, S.; Seema, S.; Gurpreet, S.; Rana, a C.; Baibhav, J. (2011) Penetration Enhancers : a Novel Strategy for Enhancing Transdermal Drug Delivery. Res. J. Pharm., 2 (12), 32?36.
  28. Vishal garg et al, (2017) Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment. AAPS PharmSciTech.18(1), 58-71.
  29. Wong, C. S. M.; Strange, R. C.; Lear, J. T.(2003) Clinical review Basal cell carcinoma., 327 (October).
  30. Zhang, Z.; Wang et.al,(2016) 5-Fluorouracil-Loaded Transfersome as Theranostics in Dermal Tumor of Hypertrophic Scar Tissue 5-Fluorouracil-Loaded Transfersome as Theranostics in Dermal Tumor of Hypertrophic Scar Tissue., 10.11.

[Jessy Shaji and Rinki Bajaj. (2018); OPTIMIZATION AND CHARACTERIZATION OF 5-FLUOROURACIL TRANSETHOSOMES FOR SKIN CANCER THERAPY USING RESPONSE SURFACE METHODOLOGY. Int. J. of Adv. Res. 6 (Mar). 1225-1233] (ISSN 2320-5407). www.journalijar.com

Jessy Shaji
Dept of Pharmaceutics, Prin. K. M. Kundnani College of Pharmacy, Cuffe Parade, Mumbai 400005, India

DOI:

Article DOI: 10.21474/IJAR01/6789      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6789

Download Full Paper

Download PDF No. of Downloads: 96 | No. of Views: 260